Thanks,
Of course it would be nice to see a PSTI product in such testing, which I doubt is the case. While it's very possible what China is using may violate a PSTI patent, trying to win that battle with the Chinese would be a major effort the way they ignore intellectual property there.
It's at least an indication that others believe in the technology. To me the real question is, without any modification, would our radiation product work well in pneumonia. If that were the case, I believe that we have sufficient product to at least get a lot of patients started. It would also be good to know if one dose would be sufficient, or if it would take many until the patient is cured.
As I understand it, the coronavirus, like the flu, will run it's course in a matter of weeks after it presents. If you can cure the pneumonia it often creates, you'll be fine. In the course of my life I've had pneumonia a few times, in some cases walking pneumonia that hardly restricted me at all. After acquiring leukemia and getting stem cells it's occurred on a couple occasions and while I didn't feel that terrible, in each case I was put in the hospital until I was through the worst of it. I'm now approaching 5 years post stem cells, I don't know that pneumonia would immediately put me into the hospital today, but I'd rather not find out. I suspect our hospitals will be overwhelmed with patients as coronavirus spreads unless something is found that lessens it's threat. If our drug were found to be effective, it could be administered without hospital admission, and as long as it worked, patients would get better.
It would be nice to see a trial anywhere in the world where our drug was specified in the treatment. It would be great if they found a sponsor, but if not, if they sponsored a small trial themselves the stock would probably respond very favorably, and if some dilutive financing were required to pay for the trial, at least it would be at a higher price.
I know people believe it may already be happening in Israel, and while that may be true, it needs to be documented to be of any advantage to the stock. It's not about preventing the disease with placental stem cells, it's about lowering the fatality percentage. The only way we'll learn if coronavirus spreads to the numbers that normal flu does is by letting it run it's course. Our President is proven wrong day after day as he makes assertions it's not that bad and the next day's data shows it's growth. I believe the real problem may be tens to hundreds of thousands of people throughout the world unsure of whether they have the common flu or coronavirus, and even when they recover, they won't know which disease they recovered from unless a sample was taken of what they had. In terms of treating the pneumonia, if we have a treatment it wouldn't matter the source, a patient with pneumonia would be far easier to deal with.
Gary
